Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / ALXO - ALX Oncology: Finally Reaching A Reasonable Buy-In Valuation

ALXO - ALX Oncology: Finally Reaching A Reasonable Buy-In Valuation

ALX Oncology Holdings Inc.

2024-06-27 04:13:22 ET

Summary

  • ALX Oncology valuation has dropped below $500 million, presenting new studies at venues like ASCO, reaching a point of inflection.
  • Evorpacept is the main focus, showing promising activity signals in gastric cancer and urothelial carcinoma, with upcoming data updates and trials.
  • Financially, ALXO has a reasonable cash pool to fund operations for the near term, with a runway of 5-6 quarters.

Topline Summary and Update

For further details see:

ALX Oncology: Finally Reaching A Reasonable Buy-In Valuation
Stock Information
Company Name: ALX Oncology Holdings Inc.
Stock Symbol: ALXO
Market: NASDAQ
Website: alxoncology.com
Menu
ALXO ALXO Quote ALXO Short ALXO News ALXO Articles ALXO Message Board
Get ALXO Alerts

News, Short Squeeze, Breakout and More Instantly...